Quantcast

Latest Treatment for depression Stories

a666250b7f7841df9e6c31dd0f9aba6e
2010-05-04 08:42:00

Trial of non-invasive treatment used new, convincing sham control Some depressed patients who don't respond to or tolerate antidepressant medications may benefit from a non-invasive treatment that stimulates the brain with a pulsing electromagnet, a study suggests. This first industry-independent, multi-site, randomized, tightly controlled trial of repetitive transcranial magnetic stimulation (rTMS) found that it produced significant antidepressant effects in a subgroup of patients, with few...

2010-04-19 14:43:03

Study finds patients report 20 times more side effects than recorded in charts A study from Rhode Island Hospital shows that patients report side effects from medication for the treatment of depression 20 times more than psychiatrists have recorded in the charts. The researchers recommend the use of a self-administered patient questionnaire in clinical practice to improve the recognition of side effects for patients in treatment. The study is published in the Journal of Clinical Psychiatry,...

2010-04-12 08:00:00

NEW YORK, April 12 /PRNewswire/ -- Fisher Wallace Laboratories today announced the results of a brain stimulation study involving the Fisher Wallace Cranial Stimulator, a portable medical device that treats depression, anxiety and insomnia. The study, published in The Neuroscientist and authored by Dr. Felipe Fregni, assistant professor in neurology at Harvard Medical School, analyzes a decade's worth of research on the brain stimulation technology used by the Fisher Wallace Cranial...

2010-03-25 06:35:00

PISGAH FOREST, N.C., March 25 /PRNewswire/ -- Pisgah Labs, a drug product development company and an active pharmaceutical ingredient manufacturer (API) located in western North Carolina, has received a patent allowance in a series of patent applications. The US Patent & Trademark Office (USPTO) has notified Pisgah Labs, Inc. (http://www.pisgahlabs.com) that a patent application related to a therapeutically significant family of pharmaceutical polymorphic compositions of imipramine...

249133790d343a854ff21438623f0197
2010-03-01 14:40:17

Conventional antidepressant treatments generally require three to four weeks to become effective, thus the discovery of treatments with a more rapid onset is a major goal of biological psychiatry. The first drug found to produce rapid improvement in mood was the NMDA glutamate receptor antagonist, ketamine. In a new issue of Biological Psychiatry, published by Elsevier, researchers from the National Institutes of Health report that another medication, scopolamine, also appears to produce...

2010-02-24 07:00:00

NEW YORK, Feb. 24 /PRNewswire/ -- Fisher Wallace Laboratories today announced that two psychiatry professors at Columbia University, Dr. Richard Brown and Dr. Andres San Martin, have prescribed the Fisher Wallace Cranial Stimulator to more than 250 patients suffering from depression, anxiety and insomnia. The handheld, FDA-sanctioned device generates micro-currents of electricity using patented radio frequencies that have been shown in several peer-reviewed studies to gently stimulate the...

8440bc2a66cdbdeaa6a3be7a82c224181
2010-02-23 10:20:00

Acupuncture appears to be an effective way to reduce depression symptoms during pregnancy, according to a first-of-its-kind study from Stanford University School of Medicine researchers. The study authors, led by Rachel Manber, PhD, professor of psychiatry and behavioral sciences, said they hope the results will raise awareness of the problem of depression during pregnancy and provide patients and physicians an alternative to antidepressants. "This standardized acupuncture protocol could be a...

2010-02-09 02:00:00

ANN ARBOR, Mich., Feb. 9 /PRNewswire/ -- People with depression generate higher absentee and disability costs on the job -- even when they are treated with antidepressants, according to a study published today in the Journal of Occupational and Environmental Medicine. The study, led by researchers from Thomson Reuters, analyzed insurance claims and employee health and productivity data for more than 22,000 patients diagnosed with depression and treated with antidepressants. Researchers...

4b9d264df0da48e7244ce0ffb753d78a
2010-02-04 09:38:39

In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting â“ž¢, in Chicago, researchers will unveil findings that show that acupuncture may be an effective treatment for depression during pregnancy. "Depression during pregnancy is an issue of concern because it has negative effects on both the mother and the baby as well as the rest of the family," said Dr. Schnyer, one of the study's authors. About...

2010-02-03 06:00:00

LAVAL, QC and PRINCETON, NJ, Feb. 3 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'